Jump to content
RemedySpot.com

LDN and Cancer..repost

Rate this topic


Recommended Posts

Guest guest
Posted

Repost./

LDN exerts its beneficial effects by reducing inflammation and

oxidative stress, modulating the immune system, and inhibiting cancer

cell proliferation.

Naltrexone is an opiate antagonist that preferentially blocks the mu

opiate receptor found on neuroendocrine and immune system cells. The

consequences of this blockage depend on its duration. That is,

naltrexone's effects depend on how long the receptor is blocked.

HDN vs. LDN

High dose naltrexone (HDN) refers to naltrexone doses greater than 10

mg daily. Low dose naltrexone (LDN) refers to doses of naltrexone

ranging from 1 to 10 mg daily.

HDN blocks the opiate receptor continuously. This persistent blockade

prevents opiates, both endogenous or naturally occurring opiate

compounds and opiate drugs, from reacting with the opiate receptor.

Consequently, opiate medications are prevented from causing

biochemical effects.

The endogenous opiate compounds, (the endorphins, dynorphins, and

metenkephalins) are also prevented from causing their pleasurable

effects. The natural increase in endorphins caused by exercise,

acupuncture, chocolate, sunbathing, and lovemaking has no effect in

someone on HDN.

LDN blocks the opiate receptor for approximately 4 hours. This

intermittent blockade causes a rebound effect resulting in a dramatic

increase in endogenous opiate production.

LDN Dosage

LDN is generally used in doses ranging from 3-10 mg daily depending on

body weight, the patient's condition, and individual response. For

instance, patients with multiple sclerosis (MS) and muscle spasticity

generally do better on a 3 mg dose than the standard 4.5 mg dose

recommended for neurodegenerative disorders.

The most common side effects of LDN are sleep disturbances and vivid

dreams. These effects can be avoided by taking LDN in the morning.

Although early reports suggested that LDN needed to be taken at night,

studies have shown that LDN can be taken at any time. It is not

necessary to take it at night.

The Effects of LDN

The Pennsylvania State University researcher, Dr. Ian Zagon, Ph.D. has

been studying LDN for 25 years and reports that LDN's most important

effect is its ability to increase production of met-5-enkephalin,

which he named opioid growth factor (OGF) for its functional

properties. The endogenous opiates are neurotransmitters as well as

cytokines, influencing the activities of immune system cells and

having distinct biochemical effects (e.g. growth factors, neurotrophic

factors, antiviral activity, anti-tumor activity, anti-inflammatory

and pro-inflammatory effects).

OGF forms a complex or system when it reacts with the OGF receptor, a

receptor found on immune system cells and cancer cells. This system

inhibits inflammation and cancer cell growth. This system also

restores homeostasis, a natural process in which the body's cells and

systems work together to maintain health. Thus, LDN helps the body

heal itself. In certain cancers, OGF is used in place of LDN.

Dr. Jau-Shyong () Hong of the National Institute of Environmental

Health Sciences (NIEHS) discovered that LDN also prevents microglial

activation, the main cause of chronic brain inflammation. In addition,

LDN has antioxidant properties that reduce the effects of free

radicals throughout the body, thereby reducing chronic inflammation.

LDN also causes changes that reduce neuronal degeneration. As a

consequence, LDN offers protection against neurodegenerative diseases,

such as Parkinson's disease and MS. Chronic inflammation contributes

to the persistence of autoimmune disorders and is an underlying cause

of many conditions, including Crohn's disease.

By increasing endorphins, which are immunomodulators, LDN improves

immune function. Immunomodulators stimulate antibody production in

patients with immunodeficiency (HIV infection) and reduce antibody

production in patients with excessive antibody production (autoimmune

disorders, herpes, Lyme disease).

The Common Link

Doctors Zagon and Hong and other experts in the field reported that

diseases which respond favorably to LDN are diseases that benefit from

effects on cell proliferation (cancer inhibition) or from a reduction

in inflammation (neurodegenerative and autoimmune disorders,

fibromyalgia) or that benefit from the restoration of homeostasis and

immunomodulation (virtually all disorders, including infectious diseases).

Clinical Trials

To date, LDN has been studied or is undergoing clinical trials for

pancreatic and head and neck cancers, Crohn's disease, HIV/AIDS,

neuroblastoma, melanoma, autism, Parkinson's disease, lymphoma,

multiple sclerosis and fibromyalgia. There are also many anecdotal

reports that suggest LDN offers benefits in a wide range of other

autoimmune and neurodegenerative diseases and malignancies. Clinical

trials are needed to confirm the anecdotal reports.

Resources:

Wilkinson, LDNers.org

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...